PCRX
Pacira BioSciences, Inc.
NASDAQ: PCRX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$25.12
-1.72% today
Updated 2026-09-25
Market cap
$971.89M
P/E ratio
68.61
P/S ratio
1.30x
EPS (TTM)
$0.36
Dividend yield
—
52W range
$19 – $28
Volume
0.6M
Pacira BioSciences, Inc. (PCRX) Insider transactions
Net insider activity
Net buying (1,550,264 shares)
Buy transactions
55
Sell transactions
45
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-08-17 | SLONIN, JONATHAN | Chief Medical Officer | Sale | 3,040 | $23.23 | $70619.20 |
| 2026-06-11 | RIKER, LAUREN | Senior Vice President, Finance | Sale | 6,115 | $23.50 | $143702.50 |
| 2026-06-10 | YOUNG, ALETHIA | Director | Buy | 10,891 | — | — |
| 2026-06-10 | YOUNG, ALETHIA | Director | Buy | 6,405 | — | — |
| 2026-06-10 | YANG, MICHAEL J. | Director | Buy | 10,891 | — | — |
| 2026-06-10 | YANG, MICHAEL J. | Director | Buy | 6,405 | — | — |
| 2026-06-10 | WIGGANS, THOMAS G | Director | Buy | 32,675 | — | — |
| 2026-06-10 | HIRAWAT, SAMIT | Director | Buy | 10,891 | — | — |
| 2026-06-10 | HIRAWAT, SAMIT | Director | Buy | 6,405 | — | — |
| 2026-06-10 | FROIMSON, MARK | Director | Buy | 10,891 | — | — |
| 2026-06-10 | FROIMSON, MARK | Director | Buy | 6,405 | — | — |
| 2026-06-10 | CHRISTIE, CHRISTOPHER | Director | Buy | 10,891 | — | — |
| 2026-06-10 | CHRISTIE, CHRISTOPHER | Director | Buy | 6,405 | — | — |
| 2026-06-10 | BREGE, LAURA | Director | Buy | 10,891 | — | — |
| 2026-06-10 | BREGE, LAURA | Director | Buy | 6,405 | — | — |
| 2026-06-10 | BIGAL, MARCELO | Director | Buy | 10,891 | — | — |
| 2026-06-10 | BIGAL, MARCELO | Director | Buy | 6,405 | — | — |
| 2026-06-04 | WILLIAMS, KRISTEN | Chief Administrative Officer | Sale | 10,259 | $22.27 | $228467.93 |
| 2026-06-03 | WILLIAMS, KRISTEN | Chief Administrative Officer | Sale | 8,528 | $22.32 | $190344.96 |
| 2026-06-03 | SLONIN, JONATHAN | Chief Medical Officer | Sale | 4,728 | $22.32 | $105528.96 |
| 2026-06-03 | RIKER, LAUREN | Senior Vice President, Finance | Sale | 3,187 | $22.32 | $71133.84 |
| 2026-04-23 | CROSS, SHAWN | Chief Financial Officer | Sale | 12,941 | — | — |
| 2026-04-23 | CROSS, SHAWN | Chief Financial Officer | Buy | 12,941 | $16.45 | $212879.45 |
| 2026-04-22 | CROSS, SHAWN | Chief Financial Officer | Sale | 1,500 | — | — |
| 2026-04-22 | CROSS, SHAWN | Chief Financial Officer | Sale | 1,500 | $25.01 | $37515.00 |
| 2026-04-21 | CROSS, SHAWN | Chief Financial Officer | Sale | 2,845 | — | — |
| 2026-04-21 | CROSS, SHAWN | Chief Financial Officer | Buy | 2,845 | $16.45 | $46800.25 |
| 2026-04-20 | CROSS, SHAWN | Chief Financial Officer | Sale | 7,714 | — | — |
| 2026-04-20 | CROSS, SHAWN | Chief Financial Officer | Buy | 7,714 | $16.45 | $126895.30 |
| 2026-03-17 | SLONIN, JONATHAN | Chief Medical Officer | Sale | 3,261 | $22.82 | $74416.02 |
| 2026-03-17 | FROIMSON, MARK | Director | Sale | 500 | $21.81 | $10905.00 |
| 2026-02-11 | WILLIAMS, KRISTEN | Chief Administrative Officer | Buy | 54,546 | — | — |
| 2026-02-11 | TEEHAN, BRENDAN | Chief Commercial Officer | Buy | 51,714 | — | — |
| 2026-02-11 | SLONIN, JONATHAN | Chief Medical Officer | Buy | 54,546 | — | — |
| 2026-02-11 | RIKER, LAUREN | Senior Vice President, Finance | Buy | 19,273 | — | — |
| 2026-02-11 | LEE, FRANK D. | Director, Chief Executive Officer | Buy | 261,818 | — | — |
| 2026-02-11 | CROSS, SHAWN | Chief Financial Officer | Buy | 49,091 | — | — |
| 2026-02-02 | WILLIAMS, KRISTEN | Chief Administrative Officer | Sale | 13,137 | $20.53 | $269702.61 |
| 2026-02-02 | RIKER, LAUREN | Senior Vice President, Finance | Sale | 4,000 | $20.81 | $83240.00 |
| 2026-01-30 | WILLIAMS, KRISTEN | Chief Administrative Officer | Sale | 17,134 | $20.54 | $351932.36 |
| 2026-01-30 | TEEHAN, BRENDAN | Chief Commercial Officer | Sale | 5,182 | $20.54 | $106438.28 |
| 2026-01-30 | SLONIN, JONATHAN | Chief Medical Officer | Sale | 6,168 | $20.54 | $126690.72 |
| 2026-01-30 | RIKER, LAUREN | Senior Vice President, Finance | Sale | 2,751 | $20.54 | $56505.54 |
| 2026-01-30 | LEE, FRANK D. | Director, Chief Executive Officer | Sale | 41,488 | $20.54 | $852163.52 |
| 2026-01-27 | HIRAWAT, SAMIT | Director | Buy | 39,291 | — | — |
| 2026-01-05 | RIKER, LAUREN | Senior Vice President, Finance | Sale | 1,416 | $24.24 | $34323.84 |
| 2026-01-02 | SLONIN, JONATHAN | Chief Medical Officer | Sale | 381 | $24.46 | $9319.26 |
| 2026-01-02 | RIKER, LAUREN | Senior Vice President, Finance | Sale | 159 | $24.46 | $3889.14 |
| 2026-01-02 | LEE, FRANK D. | Director, Chief Executive Officer | Sale | 9,272 | $24.46 | $226793.12 |
| 2025-12-31 | TEEHAN, BRENDAN | Chief Commercial Officer | Buy | 402 | $10.76 | $4326.73 |
| 2025-12-10 | CROSS, SHAWN | Chief Financial Officer | Sale | 9,104 | — | — |
| 2025-12-10 | CROSS, SHAWN | Chief Financial Officer | Sale | 9,104 | $25.14 | $228874.56 |
| 2025-12-09 | CROSS, SHAWN | Chief Financial Officer | Sale | 15,896 | — | — |
| 2025-12-09 | CROSS, SHAWN | Chief Financial Officer | Sale | 15,896 | $25.03 | $397876.88 |
| 2025-11-17 | SLONIN, JONATHAN | Chief Medical Officer | Sale | 3,960 | $24.09 | $95396.40 |
| 2025-11-10 | CROSS, SHAWN | Chief Financial Officer | Sale | 12,060 | $22.09 | $266405.40 |
| 2025-10-31 | CROSS, SHAWN | Chief Financial Officer | Sale | 6,690 | $21.38 | $143032.20 |
| 2025-09-04 | CEESAY, ABRAHAM | Director | Sale | 2,354 | $27.19 | $64005.26 |
| 2025-08-07 | BIGAL, MARCELO | Director | Sale | 4,912 | $23.67 | $116267.04 |
| 2025-08-01 | SLONIN, JONATHAN | Chief Medical Officer | Sale | 315 | $22.07 | $6952.05 |
| 2025-06-11 | YOUNG, ALETHIA | Director | Buy | 11,279 | — | — |
| 2025-06-11 | YOUNG, ALETHIA | Director | Buy | 6,163 | — | — |
| 2025-06-11 | YANG, MICHAEL J. | Director | Buy | 11,279 | — | — |
| 2025-06-11 | YANG, MICHAEL J. | Director | Buy | 6,163 | — | — |
| 2025-06-11 | KRONENFELD, MARK A. | Director | Buy | 11,279 | — | — |
| 2025-06-11 | KRONENFELD, MARK A. | Director | Buy | 9,999 | — | — |
| 2025-06-11 | KRONENFELD, MARK A. | Director | Buy | 6,163 | — | — |
| 2025-06-11 | FROIMSON, MARK | Director | Buy | 11,279 | — | — |
| 2025-06-11 | FROIMSON, MARK | Director | Buy | 6,163 | — | — |
| 2025-06-11 | CHRISTIE, CHRISTOPHER | Director | Buy | 11,279 | — | — |
| 2025-06-11 | CHRISTIE, CHRISTOPHER | Director | Buy | 6,163 | — | — |
| 2025-06-11 | CEESAY, ABRAHAM | Director | Buy | 11,279 | — | — |
| 2025-06-11 | CEESAY, ABRAHAM | Director | Buy | 6,163 | — | — |
| 2025-06-11 | BREGE, LAURA | Director | Buy | 11,279 | — | — |
| 2025-06-11 | BREGE, LAURA | Director | Buy | 6,163 | — | — |
| 2025-06-11 | BIGAL, MARCELO | Director | Buy | 11,279 | — | — |
| 2025-06-11 | BIGAL, MARCELO | Director | Buy | 6,163 | — | — |
| 2025-06-04 | WILLIAMS, KRISTEN | Chief Administrative Officer | Sale | 14,376 | $26.24 | $377226.24 |
| 2025-06-04 | RIKER, LAUREN | Senior Vice President, Finance | Sale | 5,578 | $26.21 | $146199.38 |
| 2025-06-03 | WILLIAMS, KRISTEN | Chief Administrative Officer | Sale | 6,162 | $26.40 | $162676.80 |
| 2025-06-03 | SLONIN, JONATHAN | Chief Medical Officer | Sale | 5,084 | $26.40 | $134217.60 |
| 2025-06-03 | RIKER, LAUREN | Senior Vice President, Finance | Sale | 3,374 | $26.40 | $89073.60 |
| 2025-02-04 | TEEHAN, BRENDAN | Chief Commercial Officer | Buy | 99,500 | $26.59 | $2.65M |
| 2025-02-01 | WILLIAMS, KRISTEN | Chief Administrative Officer | Buy | 79,200 | — | — |
| 2025-02-01 | TEEHAN, BRENDAN | Chief Commercial Officer | Buy | 54,000 | — | — |
| 2025-02-01 | SLONIN, JONATHAN | Chief Medical Officer | Buy | 93,600 | — | — |
| 2025-02-01 | RIKER, LAUREN | Senior Vice President, Finance | Buy | 30,600 | — | — |
| 2025-02-01 | LEE, FRANK D. | Director, Chief Executive Officer | Buy | 350,000 | — | — |
| 2025-01-06 | SLONIN, JONATHAN | Chief Medical Officer | Sale | 879 | $18.40 | $16173.60 |
| 2025-01-02 | SLONIN, JONATHAN | Chief Medical Officer | Sale | 371 | $18.33 | $6800.43 |
| 2025-01-02 | RIKER, LAUREN | Senior Vice President, Finance | Sale | 159 | $18.33 | $2914.47 |
| 2025-01-02 | LEE, FRANK D. | Director, Chief Executive Officer | Sale | 9,375 | $18.33 | $171843.75 |
| 2024-12-31 | GAUGLER, DARYL | Chief Operating Officer | Buy | 244 | $16.01 | $3907.42 |
| 2024-12-13 | GAUGLER, DARYL | Chief Operating Officer | Sale | 500 | $19.76 | $9880.00 |
| 2024-11-04 | CROSS, SHAWN | Chief Financial Officer | Buy | 200,000 | — | — |
| 2024-11-01 | CROSS, SHAWN | Chief Financial Officer | Buy | 75,000 | — | — |
| 2024-09-13 | GAUGLER, DARYL | Chief Operating Officer | Sale | 500 | $12.86 | $6430.00 |
| 2024-08-16 | BREGE, LAURA | Director | Buy | 1,000 | $12.81 | $12810.00 |
| 2024-08-16 | BIGAL, MARCELO | Director | Buy | 1,512 | $13.25 | $20034.00 |
| 2024-08-14 | YANG, MICHAEL J. | Director | Buy | 2,000 | $12.90 | $25800.00 |
Frequently asked questions
Are PCRX insiders buying or selling?
Over the transactions on record, PCRX insiders have been net buyers, with about $5.50M in stock sold across 45 sales, against 9 open-market purchases.
Does insider selling at PCRX mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which PCRX insiders are selling the most?
Recent selling is concentrated in a few names. WILLIAMS, KRISTEN accounts for the largest share on record, with about $1.58M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.